McDermott + Bull has successfully placed Hussain Rangwala as Chief Technology Officer at Inari Medical. Reporting to the CEO, Hussain will drive the development and execution of innovative R&D strategies, including fostering a culture of innovation, ensuring...
McDermott + Bull has successfully placed Helen Routh and Beverly Huss as members of the Board of Directors at Clarius Mobile Health. They will bring their vast expertise in healthcare technology and medical devices to help Clarius continue to innovate and grow. Their...
McDermott + Bull Partner Ken Dropiewski sits down with Catalyst Health Ventures Managing Partner Darshana Zaveri to discuss several key topics relevant to CEOs and investors alike. Darshana shares insights on how CEOs can best prepare for a productive meeting with...
The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
McDermott + Bull has successfully placed Tom Mock as the Director of Research and Development at NVMedTech. Tom will oversee the completion of one of the company’s main intravascular products, managing its design finalization, initiating GLP animal studies, and...
McDermott + Bull has successfully placed Mazi Kiani as Senior Vice President of Quality + Regulatory Affairs at Inari Medical. Mazi will be responsible for ensuring the highest standards of product quality and safety are achieved while navigating complex global...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
